| human | Q5 |
| P6178 | Dimensions author ID | 010116745517.37 |
| P496 | ORCID iD | 0000-0002-7860-693X |
| P1153 | Scopus author ID | 7004301145 |
| P108 | employer | Yale University | Q49112 |
| Yale School of Medicine | Q1961140 | ||
| P734 | family name | Altice | Q37256676 |
| Altice | Q37256676 | ||
| Altice | Q37256676 | ||
| P735 | given name | Frederick | Q3273004 |
| Frederick | Q3273004 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36798287 | "Bureaucracy & Beliefs": Assessing the Barriers to Accessing Opioid Substitution Therapy by People Who Inject Drugs in Ukraine. |
| Q57280940 | "You Have to Keep Yourself Hidden": Perspectives From Malaysian Malay-Muslim Men Who Have Sex With Men on Policy, Network, Community, and Individual Influences on HIV Risk |
| Q42256665 | 'Krokodil' and what a long strange trip it's been. |
| Q48033064 | A Call to Action: A Blueprint for Academic Health Sciences in the Era of Mass Incarceration. |
| Q38767686 | A Moderated Mediation Model of HIV-Related Stigma, Depression, and Social Support on Health-Related Quality of Life among Incarcerated Malaysian Men with HIV and Opioid Dependence. |
| Q38692742 | A Qualitative Assessment of Alcohol Consumption and Sexual Risk Behaviors Among Men Who Have Sex With Men and Transgender Women in Peru. |
| Q50099929 | A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis |
| Q34980073 | A comparison of psychiatric diagnoses among HIV-infected prisoners receiving combination antiretroviral therapy and transitioning to the community |
| Q36552540 | A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description |
| Q30927802 | A prospective controlled trial of routine opt-out HIV testing in a men's jail. |
| Q33892420 | A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan. |
| Q50130640 | A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine. |
| Q101136961 | A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction |
| Q37302772 | A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment. |
| Q27692040 | A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice |
| Q36390767 | A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs |
| Q34380750 | A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization |
| Q28483850 | Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers |
| Q36861872 | Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study |
| Q35762489 | Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations. |
| Q39362703 | Accessing methadone within Moldovan prisons: Prejudice and myths amplified by peers |
| Q40208874 | Active syphilis and its association with HIV and sexual risk behaviours in a multicity sample of men who have sex with men and transgender women in Peru |
| Q37406433 | Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention |
| Q35167796 | Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia |
| Q93345582 | Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety |
| Q35885979 | Adherence to HIV treatment and care among previously homeless jail detainees. |
| Q64081927 | Adherence to HIV treatment regimens: systematic literature review and meta-analysis |
| Q90838094 | Adherence to and Retention in Medications for Opioid Use Disorder among Adolescents and Young Adults |
| Q36274505 | Adherence to hepatitis B virus vaccination at syringe exchange sites |
| Q36368992 | Advancing Behavioral HIV Prevention: Adapting an Evidence-Based Intervention for People Living with HIV and Alcohol Use Disorders. |
| Q49887780 | Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review. |
| Q37723767 | Alcohol use disorders and antiretroviral therapy among prisoners in Argentina |
| Q34458805 | Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. |
| Q57665834 | All-cause mortality among people with HIV released from an integrated system of jails and prisons in Connecticut, USA, 2007–14: a retrospective observational cohort study |
| Q36642769 | An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy |
| Q52647070 | An Information-Motivation-Behavioral Skills Model of PrEP Uptake. |
| Q33874384 | An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency |
| Q33702350 | An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. |
| Q38690141 | An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru. |
| Q34924799 | An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia |
| Q36692794 | Antiretroviral treatment regimen outcomes among HIV-infected prisoners. |
| Q58571355 | Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populations |
| Q90450641 | Assessing mobile health feasibility and acceptability among HIV-infected cocaine users and their healthcare providers: guidance for implementing an intervention |
| Q40151486 | Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia |
| Q89499842 | Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine |
| Q37179100 | At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine |
| Q34676524 | Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators. |
| Q44548528 | Attitudes toward and beliefs about prenatal HIV testing policies and mandatory HIV testing of newborns among drug users. |
| Q46089681 | Attitudes toward medication-assisted treatment among fishermen in Kuantan, Malaysia, who inject drugs |
| Q34890135 | Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention |
| Q98564535 | Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs |
| Q44332797 | Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission |
| Q36508384 | Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence |
| Q37228749 | Being unaware of being HIV-infected is associated with alcohol use disorders and high-risk sexual behaviors among men who have sex with men in Peru |
| Q90413763 | Brief Report: Reduced Use of Illicit Substances, Even Without Abstinence, Is Associated With Improved Depressive Symptoms Among People Living With HIV |
| Q36655038 | Buprenorphine and HIV primary care: new opportunities for integrated treatment |
| Q35112836 | Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers |
| Q28488313 | Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community |
| Q35661041 | Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. |
| Q46515339 | Case series of buprenorphine injectors in Kuala Lumpur, Malaysia |
| Q46906513 | Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases |
| Q35538674 | Challenges in managing HIV in people who use drugs |
| Q35088386 | Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS. |
| Q30248944 | Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. |
| Q36248580 | Clinical care of the HIV-infected drug user |
| Q36843554 | Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations |
| Q39136899 | Co-calibration of two self-reported measures of adherence to antiretroviral therapy. |
| Q33691666 | Cohort profile: seek, test, treat and retain United States criminal justice cohort |
| Q35009614 | Communication technology use and mHealth acceptance among HIV-infected men who have sex with men in Peru: implications for HIV prevention and treatment |
| Q37710293 | Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets |
| Q43218767 | Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening |
| Q43980850 | Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project |
| Q52689412 | Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine. |
| Q30250218 | Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia |
| Q37281186 | Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail |
| Q28486687 | Correction: Absence of Antiretroviral Therapy and Other Risk Factors for Morbidity and Mortality in Malaysian Compulsory Drug Detention and Rehabilitation Centers |
| Q42403902 | Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola |
| Q42552281 | Correction: The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model |
| Q35754285 | Correlates and Experiences of HIV Stigma in Prisoners Living With HIV in Indonesia: A Mixed-Method Analysis. |
| Q36274335 | Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection |
| Q34169506 | Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners. |
| Q60303005 | Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia |
| Q36657743 | Correlates of having never been HIV tested among entrants to substance abuse treatment clinics: empiric findings from real-world New England settings. |
| Q37022021 | Correlates of retention in HIV care after release from jail: results from a multi-site study |
| Q36362007 | Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system |
| Q88907731 | Correlates of viral suppression among HIV-infected men who have sex with men and transgender women in Lima, Peru |
| Q38954055 | Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. |
| Q54416033 | Corrigendum to "Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community" [Contemp. Clin. Trials (2 |
| Q42342748 | Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40]. |
| Q35903617 | Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States. |
| Q35058786 | Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States |
| Q44288271 | Cost-effectiveness of HIV screening for incarcerated pregnant women |
| Q93067121 | Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: dynamic modeling analysis |
| Q54988356 | Creating, reinforcing, and resisting the gender binary: a qualitative study of transgender women's healthcare experiences in sex-segregated jails and prisons. |
| Q91642545 | Criminal justice measures for economic data harmonization in substance use disorder research |
| Q42910689 | DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions |
| Q33553259 | Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy |
| Q40212094 | Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia. |
| Q34817072 | Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. |
| Q37712289 | Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community |
| Q40628071 | Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. |
| Q80117376 | Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication |
| Q39664785 | Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication |
| Q33658647 | Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research. |
| Q102055786 | Development and Psychometric Evaluation of the PrEP Sexual Expectancies (PSEXS) Scale |
| Q37197054 | Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial |
| Q35646342 | Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions |
| Q57114591 | Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments |
| Q37393366 | Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone |
| Q91748234 | Dual motivational model of pre-exposure prophylaxis use intention: model testing among men who have sex men in Ukraine |
| Q35048206 | Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis |
| Q28483957 | Early identification of HIV: empirical support for jail-based screening |
| Q37325436 | Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. |
| Q51946467 | Editorial comment: why treat three conditions when it is one patient? |
| Q35482399 | Effect of Ebola progression on transmission and control in Liberia |
| Q92265530 | Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study |
| Q36385539 | Effect of social relationships on antiretroviral medication adherence for people living with HIV and substance use disorders and transitioning from prison |
| Q39612839 | Effectiveness of a mobile medical van in providing screening services for STDs and HIV. |
| Q80265931 | Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community |
| Q40476713 | Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial. |
| Q35112855 | Emergency department use among HIV-infected released jail detainees. |
| Q31083101 | Emergency department use by released prisoners with HIV: an observational longitudinal study |
| Q35221342 | Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission |
| Q64982916 | Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States. |
| Q90024719 | Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling |
| Q90602530 | Evaluating Physicians' Intention to Discriminate Against Patients Living with HIV in Malaysia |
| Q91287205 | Evaluation of HIV risk and outcomes in a nationally representative sample of incarcerated women in Azerbaijan, Kyrgyzstan, and Ukraine |
| Q40144817 | Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia |
| Q36079814 | Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. |
| Q33452059 | Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment |
| Q35669156 | Exploring intentions to discriminate against patients living with HIV/AIDS among future healthcare providers in Malaysia |
| Q47548700 | Extended-Release Naltrexone Improves Viral Suppression among Incarcerated Persons Living with HIV with Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial. |
| Q88753330 | Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial |
| Q38882435 | Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. |
| Q60301168 | Factors Associated with HIV Viral Suppression Among Transgender Women in Lima, Peru |
| Q46194023 | Factors Associated with Medical Doctors' Intentions to Discriminate Against Transgender Patients in Kuala Lumpur, Malaysia |
| Q40665677 | Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia |
| Q37110382 | Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy |
| Q89536780 | Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis |
| Q36758811 | Frequent emergency department use among released prisoners with human immunodeficiency virus: characterization including a novel multimorbidity index. |
| Q38966480 | Gender Differences in HIV Risk Behaviors Among Persons Involved in the U.S. Criminal Justice System and Living with HIV or at Risk for HIV: A "Seek, Test, Treat, and Retain" Harmonization Consortium |
| Q37135280 | Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail |
| Q51852535 | Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. |
| Q40813009 | Gender identity, healthcare access, and risk reduction among Malaysia's mak nyah community |
| Q55629562 | Geographic accessibility to addiction, mental health, and HIV/AIDS health-care services for opioid-dependent clients. |
| Q30248942 | Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. |
| Q90968345 | Global patterns of opioid use and dependence: harms to populations, interventions, and future action |
| Q56973152 | Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel |
| Q36551419 | HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling |
| Q57174927 | HIV Sero-Status Non-disclosure Among HIV-Infected Opioid-Dependent Individuals: The Roles of HIV-Related Stigma, Risk Behavior, and Social Support |
| Q40084795 | HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia |
| Q80832711 | HIV control efforts should directly address incarceration |
| Q34598681 | HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. |
| Q51907552 | HIV testing in correctional institutions: evaluating existing strategies, setting new standards. |
| Q36156096 | HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications |
| Q35686969 | HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study |
| Q92505810 | HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy |
| Q34758927 | HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. |
| Q58119534 | HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence among HIV-Positive Methadone-Maintained Patients |
| Q36463626 | HIV-infected men who have sex with men, before and after release from jail: the impact of age and race, results from a multi-site study. |
| Q35528959 | HIV-related research in correctional populations: now is the time |
| Q35646387 | Harnessing case isolation and ring vaccination to control Ebola |
| Q100529581 | Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam |
| Q40422150 | Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia |
| Q44349455 | Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients |
| Q37111786 | Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications |
| Q53410806 | Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine. |
| Q45324640 | Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study |
| Q35674947 | High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study |
| Q37204765 | High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes. |
| Q39399281 | High rates of unprotected anal intercourse with regular and casual partners and associated risk factors in a sample of ethnic Malay men who have sex with men (MSM) in Penang, Malaysia |
| Q40183241 | Housing Experiences among Opioid-Dependent, Criminal Justice-Involved Individuals in Washington, D.C. |
| Q44475721 | Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis |
| Q96125888 | Identifying and managing infectious disease syndemics in patients with HIV |
| Q79390341 | Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users |
| Q38623266 | Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes |
| Q36706997 | Implementing methadone maintenance treatment in prisons in Malaysia |
| Q33977281 | Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment |
| Q34774846 | Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics |
| Q34732952 | Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine |
| Q47157793 | Improving correctional healthcare providers' ability to care for transgender patients: Development and evaluation of a theory-driven cultural and clinical competence intervention. |
| Q37117229 | In Their Own Voices: Breaking the Vicious Cycle of Addiction, Treatment and Criminal Justice Among People who Inject Drugs in Ukraine. |
| Q58598733 | Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis |
| Q74527344 | Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study |
| Q37221321 | Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy |
| Q40472345 | Innovative Program Delivery and Determinants of Frequent Visitation to a Mobile Medical Clinic in an Urban Setting. |
| Q51734189 | Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. |
| Q55425578 | Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? |
| Q40128070 | Integrated Tuberculosis/Human Immunodeficiency Virus Community-Based Case Finding in Rural South Africa: Implications for Tuberculosis Control Efforts. |
| Q96612116 | Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study |
| Q36906548 | Integrating buprenorphine maintenance therapy into federally qualified health centers: real-world substance abuse treatment outcomes |
| Q37227121 | Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services |
| Q44141522 | Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative |
| Q37397043 | Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine |
| Q38885762 | Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment |
| Q37470350 | Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market |
| Q41085120 | Latent class analysis of substance use among men who have sex with men in Malaysia: Findings from the Asian Internet MSM Sex Survey. |
| Q37535337 | Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. |
| Q88065582 | Latent tuberculosis infection screening in foreign-born populations: a successful mobile clinic outreach model |
| Q37193747 | Latent tuberculosis infection: screening and treatment in an urban setting. |
| Q42352320 | Letter to the editor: regarding "individual and neighborhood correlates of membership in drug-using networks with a higher prevalence of HIV in New York City (2006-2009)". |
| Q38769642 | Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions |
| Q52597020 | Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era. |
| Q36338880 | Managing HIV/AIDS in correctional settings |
| Q48147782 | Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users. |
| Q44525491 | Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research |
| Q44147560 | Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy |
| Q41412402 | Men Who Have Sex With Men in Peru: Acceptability of Medication-Assisted Therapy for Treating Alcohol Use Disorders |
| Q37033936 | Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia |
| Q41356922 | Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine. |
| Q89723710 | Modeling Combination HCV Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the USA |
| Q46919721 | Models for integrating buprenorphine therapy into the primary HIV care setting |
| Q34005620 | Neurocognitive impairment and HIV risk factors: a reciprocal relationship |
| Q42651065 | Next steps for Ukraine abolition of HIV registries, implementation of routine human immunodeficiency virus testing and expansion of services |
| Q81468001 | Observations on implementing routine HIV testing in jails |
| Q89842937 | Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs |
| Q57455649 | Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine |
| Q33819391 | Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate |
| Q90565401 | Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment |
| Q37414837 | Partner violence and health among HIV-infected jail detainees. |
| Q40083753 | Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine. |
| Q36223839 | Patterns of homelessness and implications for HIV health after release from jail. |
| Q36816738 | Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia |
| Q54220625 | Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine. |
| Q37163341 | Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial |
| Q37830040 | Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence |
| Q87070383 | Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice |
| Q36465406 | Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice |
| Q36826482 | Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir |
| Q37425629 | Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone |
| Q36248583 | Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence |
| Q33629465 | Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia |
| Q36272498 | Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users |
| Q36691614 | Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite study. |
| Q89451159 | Pre-exposure Prophylaxis Among Men Who have Sex with Men: Dual Motivational Model of Intention to Use Pre-exposure Prophylaxis |
| Q27300526 | Pre-incarceration police harassment, drug addiction and HIV risk behaviours among prisoners in Kyrgyzstan and Azerbaijan: results from a nationally representative cross-sectional study. |
| Q47140902 | Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons. |
| Q47159420 | Predictors of Mortality within Prison and after Release among Persons Living with HIV in Indonesia |
| Q47389289 | Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study |
| Q30227266 | Preparing for highly active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model |
| Q53774218 | Preserving human rights in the era of "test and treat" for HIV prevention. |
| Q39969449 | Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach |
| Q35610989 | Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study |
| Q36223874 | Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. |
| Q37833791 | Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study |
| Q37552516 | Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. |
| Q47555908 | Prevalence, Diagnosis, and Treatment Rates of Mood Disorders among Opioid Users under Criminal Justice Supervision. |
| Q30248941 | Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners |
| Q40315442 | Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine |
| Q57114573 | Prisoner health status at three rural Haitian prisons |
| Q92168609 | Prisons: ignore them at our peril |
| Q36843549 | Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia |
| Q30377895 | Public health and international drug policy. |
| Q35164557 | Public health implications for adequate transitional care for HIV-infected prisoners: five essential components |
| Q114300989 | Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs |
| Q79211911 | Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach |
| Q102063088 | Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine |
| Q92960112 | Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study |
| Q35712988 | Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes |
| Q42625921 | Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study |
| Q59827667 | Relying on Injection Drug Users to Access and Adhere to HIV Therapeutics |
| Q59573824 | Reply to Letter “Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al” |
| Q99552301 | Response to the COVID-19 Outbreak in Urban Settings in China |
| Q103808801 | Response to the COVID-19 Outbreak in Urban Settings in China |
| Q57291942 | Retention in HIV care during the 3 years following release from incarceration: A cohort study |
| Q91860638 | Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia |
| Q38628748 | Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic |
| Q28729018 | Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners |
| Q28265279 | Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence |
| Q36776090 | Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia |
| Q30927775 | Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. |
| Q90065308 | Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy |
| Q28535165 | Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru |
| Q41441944 | Self-management of buprenorphine/naloxone among online discussion board users. |
| Q53423564 | Sex-Related Disparities in Criminal Justice and HIV Treatment Outcomes: A Retrospective Cohort Study of HIV-Infected Inmates. |
| Q41525221 | Sexual risk behaviors among adolescents in Port-au-Prince, Haiti |
| Q38820080 | Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review |
| Q128791982 | Stalled scale-up of opioid agonist therapies for HIV prevention in Kazakhstan: history, policy, and recommendations for change |
| Q92270892 | Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs |
| Q36479621 | Stigma Toward Men Who Have Sex with Men Among Future Healthcare Providers in Malaysia: Would More Interpersonal Contact Reduce Prejudice? |
| Q64323422 | Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study |
| Q42199183 | Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic |
| Q80481731 | Strategies for primary HIV prevention that target behavioral change |
| Q47584059 | Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in Ukraine. |
| Q37846587 | Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. |
| Q35088770 | Substance abuse, violence, and HIV in women: a literature review of the syndemic. |
| Q37221318 | Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial |
| Q28481405 | Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa |
| Q34766519 | Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users |
| Q60141172 | Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention |
| Q37035765 | The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment |
| Q36275929 | The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review : Alcohol and the HIV Continuum of Care |
| Q60047954 | The Impact of Housing and HIV Treatment on Health-Related Quality of Life Among People With HIV Experiencing Homelessness or Unstable Housing |
| Q35532871 | The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model |
| Q60047953 | The Influence of Housing Status on the HIV Continuum of Care: Results From a Multisite Study of Patient Navigation Models to Build a Medical Home for People Living With HIV Experiencing Homelessness |
| Q35785892 | The Influence of Medication Attitudes on Utilization of Antiretroviral Therapy (ART) in Indonesian Prisons |
| Q38829492 | The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis. |
| Q95306734 | The Real-World Impact of Dosing of Methadone and Buprenorphine on Retention on Opioid Agonist Therapies in Ukraine |
| Q58567307 | The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: an integrated analysis |
| Q40203457 | The association between history of violence and HIV risk: a cross-sectional study of HIV-negative incarcerated women in Connecticut |
| Q21559628 | The burgeoning HIV/HCV syndemic in the urban Northeast: HCV, HIV, and HIV/HCV coinfection in an urban setting |
| Q39377856 | The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling |
| Q28536945 | The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia |
| Q44350723 | The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine |
| Q34743029 | The impact of needle exchange-based health services on emergency department use. |
| Q52615937 | The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. |
| Q28077903 | The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia |
| Q36655045 | The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention |
| Q36372996 | The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: Important targets for intervention. |
| Q46973558 | Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir |
| Q96586449 | Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes |
| Q92349092 | Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes |
| Q30751889 | Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs |
| Q36593410 | Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia |
| Q33911429 | Trials and tribulations of conducting bio-behavioral surveys in prisons: implementation science and lessons from Ukraine |
| Q37536255 | Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. |
| Q34068801 | Ukrainian prisoners and community reentry challenges: implications for transitional care |
| Q36449114 | Under-reporting and case fatality estimates for emerging epidemics |
| Q33725810 | Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail |
| Q39193920 | Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community |
| Q92379134 | Use of Smartphone to Seek Sexual Health Information Online Among Malaysian Men Who Have Sex with Men (MSM): Implications for mHealth Intervention to Increase HIV Testing and Reduce HIV Risks |
| Q102387229 | Using individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis |
| Q41993382 | Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine |
| Q92534027 | Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support |
| Q35618756 | Validation of a Brief Measure of Opioid Dependence: The Rapid Opioid Dependence Screen (RODS) |
| Q36698135 | Validation of the 'drinking expectancy questionnaire for men who have sex with men' in Peru. |
| Q47568447 | Why People Who Inject Drugs Voluntarily Transition Off Methadone in Ukraine. |
| Q99408022 | Willingness to Use HIV Self-Testing and Associated Factors Among Transgender Women in Malaysia |
| Q40404705 | Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment. |
| Q38719086 | Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. |
| Q34105570 | Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour |
| Q35557400 | Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice |
Search more.